Hemispherx Biopharma, Inc. CEO Interviewed on CEOLIVE.TV

by Barry101 | Nov 15, 2017 | Press Release

PHILADELPHIA, Nov. 15, 2017 — Hemispherx Biopharma, Inc. (NYSE American:HEB), based in Philadelphia, focused on pharmaceuticals, today announced that Thomas K. Equels, M.S. J.D., Chief Executive Officer, was interviewed on CEOLIVE.TV on November 13, 2017.The...

Hemispherx Biopharma Announces Corporate Progress and Financial Results for the Nine Months Ended September 30, 2017

by Barry101 | Nov 15, 2017 | Press Release

PHILADELPHIA, Nov. 15, 2017 — Hemispherx Biopharma (NYSE American:HEB) announced today its financial results for the third quarter ended September 30, 2017.The net loss was $1.3 million for the three months ended September 2017 compared to $2.9 million in this...

Hemispherx Biopharma Announces Corporate Progress and Financial Results for the Six Months Ended June 30, 2017

by Barry101 | Aug 15, 2017 | Press Release

The Company has Generated Revenues and Advanced in R&D for Intranasal Ampligen and in Immuno-OncologyConference Call Scheduled for Tuesday, August 15th at 1:00 PM EDTPHILADELPHIA, Aug. 15, 2017 — Hemispherx Biopharma (NYSE MKT:HEB): This quarter we see...

Hemispherx Human Safety Study of Intranasal Ampligen® with Influenza Vaccine Shows Ampligen was Generally Well-Tolerated

by Barry101 | Aug 14, 2017 | Press Release

PHILADELPHIA, Aug. 14, 2017 — Hemispherx Biopharma (NYSE MKT:HEB) announced that it has commenced full data analysis of an intranasal human safety study of Ampligen® plus FluMist® known as AMP-600. The study was previously closed, but the initiation of...

Hemispherx Biopharma to Host Conference Call to Discuss Second Quarter Financial Results on Tuesday, August 15, 2017

by Barry101 | Aug 11, 2017 | Press Release

Financials for Second Quarter Ended June 30, 2017 will be released on August 14, 2017PHILADELPHIA, Aug. 11, 2017 — Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the “Company” or “Hemispherx”) announced today that it anticipates filing its...

Hemispherx Biopharma Announces Collaboration with Millions Missing Canada to Bring Medication to Canadians for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

by Barry101 | Aug 8, 2017 | Press Release

Advocacy Organization to Work with Health Canada with the Goal to Gain ApprovalPHILADELPHIA, Aug. 08, 2017 — Hemispherx Biopharma (NYSE MKT:HEB) has announced that on Thursday, August 3, 2017 it participated in a meeting in Toronto, Canada with Canadian...